Matthew Autterson is the current president and chief executive officer at CNS Biosciences, Inc, a drug research facility which studies substances and their positive application to treat several diseases. Born in Detroit, Michigan, Matthew Autterson dreamed of becoming a successful individual when he grew up. He chose to study at the Michigan State University when he was in college, and he has shown an exceptional passion to excel. He graduated in 1979 and received his Bachelor of Arts degree in Finance. After graduating from the Michigan State Unviersity, Matthew Autterson thought that his knowledge in the finance sector is not enough, so he enrolled himself at the University of Denver Graduate Tax Program. He would later use the knowledge that he learned from the university to become a successful investment management professional.
After graduating from the university, Matthew Autterson looked for a job that is closely related to skills. While searching for a job, one company caught his attention. It was the First Trust Corporation, a financial firm which focuses on trusts and other financial investments. The First Trust Corporation is a subsidiary of Fiserv, and Matthew Autterson thought that working with them will enhance his knowledge and skill about how the financial sector works. He joined the company and worked with them for a limited time, until Autterson had the idea to join a small financial startup based in Colorado. He left the First Trust Corporation to work with the Resources Trust Company, and the decision that he made was worth it, because he would later be appointed as the company’s president. Click Here For More Info.
Matthew Autterson transferred to Colorado after getting a stable job with the Resources Trust Company, but after serving for a number of years, he decided to leave. Several factors affected his decision to move from working in the financial sector to the pharmaceutical sector, and one of them is his curiosity on how other industries worked. Today, he is working hand in hand with the founder of CNS Biosciences, Scott Falci, to develop medicinal drugs that would cure neuropathic pain. He is also serving as one of the board members for Falci Adaptive Biosystems, which is also under the umbrella of the corporation owned by Scott Falci. Aside from his stint as an executive for Falci Adaptive Biosystems, Matthew Autterson is also busy with his philanthropic activities. He is known to donate a significant amount of cash to organizations, foundations and charities which are helping people who are suffering from neurological motor disorder.
More on: http://matthewautterson.com/